181 related articles for article (PubMed ID: 34255071)
1. Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer.
Choi E; Sanyal N; Ding VY; Gardner RM; Aredo JV; Lee J; Wu JT; Hickey TP; Barrett B; Riley TL; Wilkens LR; Leung AN; Le Marchand L; Tammemägi MC; Hung RJ; Amos CI; Freedman ND; Cheng I; Wakelee HA; Han SS
J Natl Cancer Inst; 2022 Jan; 114(1):87-96. PubMed ID: 34255071
[TBL] [Abstract][Full Text] [Related]
2. Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Choi E; Luo SJ; Ding VY; Wu JT; Kumar AV; Wampfler J; Tammemägi MC; Wilkens LR; Aredo JV; Backhus LM; Neal JW; Leung AN; Freedman ND; Hung RJ; Amos CI; Le Marchand L; Cheng I; Wakelee HA; Yang P; Han SS
Cancer; 2024 Mar; 130(5):770-780. PubMed ID: 37877788
[TBL] [Abstract][Full Text] [Related]
3. Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked.
Choi E; Su CC; Wu JT; Aredo JV; Neal JW; Leung AN; Backhus LM; Lui NS; Le Marchand L; Stram DO; Liang SY; Cheng I; Wakelee HA; Han SS
JAMA Netw Open; 2023 Nov; 6(11):e2343278. PubMed ID: 37966839
[TBL] [Abstract][Full Text] [Related]
4. Tobacco Smoking and Risk of Second Primary Lung Cancer.
Aredo JV; Luo SJ; Gardner RM; Sanyal N; Choi E; Hickey TP; Riley TL; Huang WY; Kurian AW; Leung AN; Wilkens LR; Robbins HA; Riboli E; Kaaks R; Tjønneland A; Vermeulen RCH; Panico S; Le Marchand L; Amos CI; Hung RJ; Freedman ND; Johansson M; Cheng I; Wakelee HA; Han SS
J Thorac Oncol; 2021 Jun; 16(6):968-979. PubMed ID: 33722709
[TBL] [Abstract][Full Text] [Related]
5. The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer.
Choi E; Luo SJ; Aredo JV; Backhus LM; Wilkens LR; Su CC; Neal JW; Le Marchand L; Cheng I; Wakelee HA; Han SS
J Natl Cancer Inst; 2022 Apr; 114(4):618-625. PubMed ID: 34893871
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification for Second Primary Lung Cancer.
Han SS; Rivera GA; Tammemägi MC; Plevritis SK; Gomez SL; Cheng I; Wakelee HA
J Clin Oncol; 2017 Sep; 35(25):2893-2899. PubMed ID: 28644772
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy was associated with the lower incidence of metachronous second primary lung cancer.
Hu ZG; Tian YF; Li WX; Zeng FJ
Sci Rep; 2019 Dec; 9(1):19283. PubMed ID: 31848368
[TBL] [Abstract][Full Text] [Related]
9. Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study.
Luo SJ; Choi E; Aredo JV; Wilkens LR; Tammemägi MC; Le Marchand L; Cheng I; Wakelee HA; Han SS
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34611582
[TBL] [Abstract][Full Text] [Related]
10. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic profiling for second primary lung cancer: A pilot case-control study.
Aredo JV; Purington N; Su L; Luo SJ; Diao N; Christiani DC; Wakelee HA; Han SS
Lung Cancer; 2021 May; 155():61-67. PubMed ID: 33743383
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer.
Fisher A; Kim S; Farhat D; Belzer K; Milczuk M; French C; Mamdani H; Sukari A; Baciewicz F; Schwartz AG; Wozniak A; Nagasaka M
Clin Lung Cancer; 2021 Nov; 22(6):e842-e850. PubMed ID: 34053862
[TBL] [Abstract][Full Text] [Related]
13. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract][Full Text] [Related]
14. Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors.
Hu ZG; Li WX; Ruan YS; Zeng FJ
PLoS One; 2018; 13(12):e0209002. PubMed ID: 30557376
[TBL] [Abstract][Full Text] [Related]
15. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
Donin NM; Kwan L; Lenis AT; Drakaki A; Chamie K
Cancer Causes Control; 2019 May; 30(5):465-475. PubMed ID: 30900065
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
17. Does irradiation for initial primary lung cancer affect the risk of metachronous second primary lung cancer?
Song X; Hu Z; Tian Y; Guo Y
Radiat Environ Biophys; 2021 Aug; 60(3):475-483. PubMed ID: 34191096
[TBL] [Abstract][Full Text] [Related]
18. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
